CU23868B1 - Hormonas de administración transdérmica que no necesitan potenciadores de penetración - Google Patents

Hormonas de administración transdérmica que no necesitan potenciadores de penetración

Info

Publication number
CU23868B1
CU23868B1 CU20100143A CU20100143A CU23868B1 CU 23868 B1 CU23868 B1 CU 23868B1 CU 20100143 A CU20100143 A CU 20100143A CU 20100143 A CU20100143 A CU 20100143A CU 23868 B1 CU23868 B1 CU 23868B1
Authority
CU
Cuba
Prior art keywords
potentiators
hormones
transdermal administration
penetration
need
Prior art date
Application number
CU20100143A
Other languages
English (en)
Spanish (es)
Other versions
CU20100143A7 (es
Inventor
Stefan Bracht
Michael Dittgen
Petra Huber
Thomas Langguth
Dirk Schenk
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34702342&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CU23868(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of CU20100143A7 publication Critical patent/CU20100143A7/es
Publication of CU23868B1 publication Critical patent/CU23868B1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Botany (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
CU20100143A 2003-12-12 2010-07-05 Hormonas de administración transdérmica que no necesitan potenciadores de penetración CU23868B1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US52871803P 2003-12-12 2003-12-12
EP03078881 2003-12-12
PCT/IB2004/052752 WO2005058287A2 (fr) 2003-12-12 2004-12-10 Administration transdermique d'hormones sans utilisation d'un agent facilitant la penetration

Publications (2)

Publication Number Publication Date
CU20100143A7 CU20100143A7 (es) 2011-10-31
CU23868B1 true CU23868B1 (es) 2013-03-27

Family

ID=34702342

Family Applications (1)

Application Number Title Priority Date Filing Date
CU20100143A CU23868B1 (es) 2003-12-12 2010-07-05 Hormonas de administración transdérmica que no necesitan potenciadores de penetración

Country Status (15)

Country Link
JP (1) JP4965263B2 (fr)
KR (1) KR101168449B1 (fr)
CN (1) CN1913878B (fr)
AU (1) AU2004298930B2 (fr)
BR (1) BRPI0417530B8 (fr)
CA (1) CA2549916C (fr)
CU (1) CU23868B1 (fr)
EA (1) EA011160B1 (fr)
EC (1) ECSP066694A (fr)
IL (1) IL176112A (fr)
MX (1) MXPA06006682A (fr)
NO (1) NO341989B1 (fr)
NZ (1) NZ548091A (fr)
WO (1) WO2005058287A2 (fr)
ZA (1) ZA200605713B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100704825B1 (ko) 2003-02-21 2007-04-09 바이엘 쉐링 파마 악티엔게젤샤프트 Ｕｖ 안정성 경피 치료 플라스터
US8962013B2 (en) 2005-05-02 2015-02-24 Bayer Intellectual Property Gmbh Multi-layered transdermal system with triazine UV absorber
DE102005050729A1 (de) * 2005-10-19 2007-04-26 Schering Ag Verfahren zur präventiven bedarfsweisen hormonalen Kontrazeption
FR2900048B1 (fr) * 2006-04-21 2012-11-16 Oreal Compositions comprenant un derive diphenyl-methane hydroxyle
AU2015203180B2 (en) * 2010-09-06 2016-06-30 Bayer Intellectual Property Gmbh Transdermal therapeutic systems with crystallization-inhibiting protective film (release liner)
DE102010040299A1 (de) * 2010-09-06 2012-03-08 Bayer Schering Pharma Aktiengesellschaft Transdermale therapeutische Systeme mit kristallisationsinhibierender Schutzfolie (Release Liner)
WO2012031999A2 (fr) 2010-09-06 2012-03-15 Bayer Pharma Aktiengesellschaft Timbres transdermiques faiblement dosés avec une libération élevée de médicament
EP2806862A2 (fr) * 2012-01-27 2014-12-03 Agile Therapeutics, Inc. Administration d'hormones par voie transdermique
HK1251938A1 (zh) * 2015-05-18 2019-05-03 敏捷治疗公司 避孕组合物及提高效能和调节副作用的方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0394429B1 (fr) * 1988-10-27 1996-01-10 Schering Aktiengesellschaft Preparation pour application transcutanee renfermant du gestodene
US5512292A (en) * 1990-10-29 1996-04-30 Alza Corporation Transdermal contraceptive formulations methods and devices
NZ240358A (en) * 1990-10-29 1994-09-27 Alza Corp Transdermal contraceptive device comprising (as active agents) an estrogen and a gestodene together with a skin permeation enhancer
DE4329242A1 (de) * 1993-08-26 1995-03-02 Schering Ag Mittel zur transdermalen Applikation enthaltend Gestodenester
DE4405898A1 (de) * 1994-02-18 1995-08-24 Schering Ag Transdermale therapeutische Systeme enthaltend Sexualsteroide
KR970706805A (ko) * 1994-11-18 1997-12-01 나까토미 히로타카 경피흡수첩부제(percutaneously absorbable patch)
CN1188189C (zh) * 1995-06-07 2005-02-09 奥瑟－麦内尔制药公司 基质层含有17－脱乙酰基诺孕酯的经皮贴片及基质的用途
JP4346696B2 (ja) * 1996-05-28 2009-10-21 久光製薬株式会社 経皮治療用装置
JP4167750B2 (ja) * 1997-04-16 2008-10-22 久光製薬株式会社 経皮吸収用基剤及び該基剤を含有する経皮吸収製剤
JP4399044B2 (ja) * 1998-10-14 2010-01-13 久光製薬株式会社 吸収促進剤及び該吸収促進剤を有してなる経皮吸収製剤
DE19906152B4 (de) * 1999-02-10 2005-02-10 Jenapharm Gmbh & Co. Kg Wirkstoffhaltige Laminate für Transdermalsysteme
WO2001001990A1 (fr) * 1999-07-01 2001-01-11 Hisamitsu Pharmaceutical Co., Inc. Preparation adhesive pour absorption percutanee
DE10053375C1 (de) * 2000-10-27 2002-01-24 Lohmann Therapie Syst Lts Transdermale therapeutische Systeme mit lichtempfindlichen Wirkstoffen
AU2002235155A1 (en) * 2000-12-05 2002-06-18 Noven Pharmaceuticals, Inc. Crystallization inhibition of drugs in transdermal drug delivery systems

Also Published As

Publication number Publication date
CN1913878A (zh) 2007-02-14
EA011160B1 (ru) 2009-02-27
NO341989B1 (no) 2018-03-12
CA2549916C (fr) 2013-09-17
KR20060128910A (ko) 2006-12-14
BRPI0417530B8 (pt) 2021-05-25
JP2007513938A (ja) 2007-05-31
NO20062594L (no) 2006-07-10
EA200601089A1 (ru) 2006-12-29
CU20100143A7 (es) 2011-10-31
ECSP066694A (es) 2006-10-31
IL176112A0 (en) 2006-10-05
CA2549916A1 (fr) 2005-06-30
AU2004298930B2 (en) 2009-11-26
CN1913878B (zh) 2010-05-26
MXPA06006682A (es) 2006-08-11
KR101168449B1 (ko) 2012-07-25
AU2004298930A1 (en) 2005-06-30
WO2005058287A2 (fr) 2005-06-30
JP4965263B2 (ja) 2012-07-04
IL176112A (en) 2011-02-28
ZA200605713B (en) 2008-01-08
NZ548091A (en) 2009-12-24
BRPI0417530A (pt) 2007-03-13
WO2005058287A3 (fr) 2006-03-02
BRPI0417530B1 (pt) 2018-01-23

Similar Documents

Publication Publication Date Title
CU23868B1 (es) Hormonas de administración transdérmica que no necesitan potenciadores de penetración
NO20054682D0 (no) Sikker transdermal doseringsform
DK3395396T3 (da) Plaster-lignende infusionsindretning
AT507045A5 (de) Implantierbare, gewebe-stimulierende vorrichtung
ITRM20020378A1 (it) Dispositivo iniettore ipodermico attivabile.
DE602005007447D1 (de) Axiale Verriegelungseinrichtung mit Verriegelungskeil
NO20055186D0 (no) Fjellbolt
DE602004017700D1 (de) Transmukosen verabreichung
ATE333271T1 (de) Uv-stabiles transdermales pflaster
ECSP055888A (es) Derivados de aril-quinazolin/aril-2-amino-fenil metanona que promueven la liberación de la hormona paratiroides.
EP1612795A4 (fr) Systeme de mise en forme
NO20044269L (no) Smamolekylaere inntrengningsinhibitorer
NO20041865D0 (no) Pressbar sprengstoffkomposisjon
PT2138169E (pt) Administração transdérmica de hormonas sem a necessidade de intensificadores de penetração
DE602004022010D1 (de) Sicherheitsspritze
NL1030786A1 (nl) Schermbeeldverhoudingstoestel en -werkwijze.
SM200400022A (it) Composti farmaceutici transdermici
BE1015485B5 (nl) Boorinrichting.
EP1831478A4 (fr) Élément de renforcement de pénétration
FR2838970B1 (fr) Seringue de securite
EP1831477A4 (fr) Élément de renforcement de pénétration
FI20021817A0 (fi) Kanyyli
ITAR20030003A1 (it) Dispositivo e metodo con cui ornare le unghie.
SK4398U (sk) Zabezpečovacie zariadenie
SE0402821L (sv) Pyroteknisk anordning

Legal Events

Date Code Title Description
FG Grant of patent